Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 275

1.

DR5 receptor mediates anoikis in human colorectal carcinoma cell lines.

Laguinge LM, Samara RN, Wang W, El-Deiry WS, Corner G, Augenlicht L, Mishra L, Jessup JM.

Cancer Res. 2008 Feb 1;68(3):909-17. doi: 10.1158/0008-5472.CAN-06-1806.

2.

Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines.

Jaganathan J, Petit JH, Lazio BE, Singh SK, Chin LS.

Neurosurg Focus. 2002 Sep 15;13(3):ecp1.

PMID:
15844877
3.
4.
6.
7.

Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.

Poulaki V, Mitsiades CS, McMullan C, Fanourakis G, Negri J, Goudopoulou A, Halikias IX, Voutsinas G, Tseleni-Balafouta S, Miller JW, Mitsiades N.

Invest Ophthalmol Vis Sci. 2005 Jan;46(1):358-66.

PMID:
15623796
8.

Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.

Maduro JH, de Vries EG, Meersma GJ, Hougardy BM, van der Zee AG, de Jong S.

Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):543-52. doi: 10.1016/j.ijrobp.2008.06.1902.

PMID:
18793956
9.

Lipoxygenase inhibitors induce death receptor 5/TRAIL-R2 expression and sensitize malignant tumor cells to TRAIL-induced apoptosis.

Yoshida T, Shiraishi T, Horinaka M, Nakata S, Yasuda T, Goda AE, Wakada M, Mizutani Y, Miki T, Nishikawa A, Sakai T.

Cancer Sci. 2007 Sep;98(9):1417-23. Epub 2007 Jul 23.

11.

DNMT1 and DNMT3b silencing sensitizes human hepatoma cells to TRAIL-mediated apoptosis via up-regulation of TRAIL-R2/DR5 and caspase-8.

Kurita S, Higuchi H, Saito Y, Nakamoto N, Takaishi H, Tada S, Saito H, Gores GJ, Hibi T.

Cancer Sci. 2010 Jun;101(6):1431-9. doi: 10.1111/j.1349-7006.2010.01565.x. Epub 2010 Mar 13.

12.

Expression of TRAIL and the death receptors DR4 and DR5 correlates with progression of degeneration in human intervertebral disks.

Bertram H, Nerlich A, Omlor G, Geiger F, Zimmermann G, Fellenberg J.

Mod Pathol. 2009 Jul;22(7):895-905. doi: 10.1038/modpathol.2009.39. Epub 2009 Mar 20.

13.

Lupulone, a hop bitter acid, activates different death pathways involving apoptotic TRAIL-receptors, in human colon tumor cells and in their derived metastatic cells.

Lamy V, Roussi S, Chaabi M, Gossé F, Lobstein A, Raul F.

Apoptosis. 2008 Oct;13(10):1232-42. doi: 10.1007/s10495-008-0250-5.

PMID:
18726190
14.
15.

Adenovirus E1A reverses the resistance of normal primary human lung fibroblast cells to TRAIL through DR5 upregulation and caspase 8-dependent pathway.

Zhu H, Ling W, Hu B, Su Y, Qiu S, Xiao W, Qi Y.

Cancer Biol Ther. 2006 Feb;5(2):180-8. Epub 2006 Feb 15.

PMID:
16357524
16.

TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8.

Belyanskaya LL, Ziogas A, Hopkins-Donaldson S, Kurtz S, Simon HU, Stahel R, Zangemeister-Wittke U.

Lung Cancer. 2008 Jun;60(3):355-65. Epub 2008 Feb 21.

PMID:
18093694
17.

P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.

Park SJ, Wu CH, Choi MR, Najafi F, Emami A, Safa AR.

Biochem Pharmacol. 2006 Jul 28;72(3):293-307. Epub 2006 May 4.

PMID:
16753135
18.

Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L).

Guseva NV, Rokhlin OW, Taghiyev AF, Cohen MB.

Breast Cancer Res Treat. 2008 Feb;107(3):349-57. Epub 2007 Apr 24.

PMID:
17453339
19.
20.

Supplemental Content

Support Center